Entegris, Inc.

Catalent provides fill/finish services across a range of product formats from clinical to commercial scale.

Shorten clinical development timeline using novel GPEx® Lightning cell line development technology.

Accelerate your downstream purification with high yield, high recovery & fewer cycles and a faster route to market.

The BIOne 10L SUB is highly innovative with expanded processing capabilities, ideal for scale-down modeling, material generation, and process optimization.

CDMO Catalent’s UpTempo℠ adeno-associated viral (AAV) platform process accelerates time from gene to clinic.

The 2023 PDA Annual Meeting is heading to New Orleans, LA, April 3-5.